Autolus Therapeutics plc (AUTL)

NMS – Real Time Price. Currency in USD

2.13

-0.20 (-8.37%)

Market open: Aug 12, 2026, 2:04 PM EDT

2.35

+0.02 (0.86%)

Previous after-hours: Aug 11, 2026, 7:52 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

76M

10M

Cost of goods sold

-97M

-19M

-7M

Gross Profit

-21M

-9M

-5M

-1M

Operating expenses (excl. COGS)

-260M

-212M

-191M

-166M

Operating Income

-281M

-221M

-196M

-168M

Non-operating income, total

-15M

22M

-33M

-6M

Pretax income

-297M

-200M

-229M

-173M

Equity in earnings

Taxes

-21M

20M

24M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-288M

-221M

-209M

-149M

Discontinued operations

Net income

-288M

-221M

-209M

-149M

Dilution adjustment

Preferred dividends

Autolus Therapeutics plc (AUTL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Autolus Therapeutics plc (AUTL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Autolus Therapeutics plc (AUTL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Autolus Therapeutics plc (AUTL)

Income Statement (Annual)

Income Statement (Annual)